Download this page for PDF version
Purpose:
Globalization of development, manufacturing, trade, and marketing of pharmaceutical drugs has been progressing, and cooperation of regulatory activities amongst pharmaceutical regulatory agencies of each region has become a necessity. Nowadays, Asian countries have become significant in clinical development and manufacturing of drugs globally, and therefore, the collaborative relationship among the Asian regulatory agencies are becomes highly important. This symposium is the first joint conference being hosted by East Asia Relations Commission and Interchange Association, Japan, with focus on pharmaceutical regulations and health insurance system. The aim of this joint conference is to enhance mutual understandings, and to construct a basis in a cooperative system across the region for further development in pharmaceutical regulations and health insurance system. In a related development, between Japan and Taiwan, that both chairman Association on November 5, the Association of East Asian Relations has signed the MOU of 5 items including pharmaceutical, further exchanges increase future is expected.
Host:
East Asia Relations Commission
Interchange Association, Japan
Cohost:
Japan Pharmaceutical Manufacturers Association (JPMA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Center for Drug Evaluation, Taiwan (CDE)
International Research-Based Pharmaceutical Manufacturers Association (IRPMA)
Taiwan Pharmaceutical Manufacturers Association (TPMA)
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)
Date
23rd to 24th December, 2013
Venue
NTUH International Convention Center
Address:
No. 2, Xuzhou Road, Zhongzheng District 100, Taipei City
Phone
+886-2-77240-109
Number of the attendees
200 attendees
Registration
Registration is accepted only in Taiwan.
Translation
Simultaneous translation to be provided for Japanese and Chinese
Agenda
Day 1 (December 23rd)
Director, Economic Affairs Division, MHLW
Deputy Director, Medical Review and Pharmaceutical Benefit Division, NHIA
Review of New Drugs
Day 2 (December 24th)
Prices for Innovative Drugs and Patent-Expired Drugs